Cell Processing Instruments Market Share, Size, Trends, Industry Analysis Report – By Type (Cell Counters, Cell Imaging Systems, Flow Cytometers, Cell Separator Systems, Automated Cell Processing Systems, and Others), Application, End-use, and Region; Mar

Cell Processing Instruments Market Share, Size, Trends, Industry Analysis Report – By Type (Cell Counters, Cell Imaging Systems, Flow Cytometers, Cell Separator Systems, Automated Cell Processing Systems, and Others), Application, End-use, and Region; Market Forecast, 2025–2034

The cell processing instruments market size is expected to reach USD 12.49 billion by 2034, according to a new study by Polaris Market Research. The report “Cell Processing Instruments Market Size, Share, Trends, Industry Analysis Report – By Type (Cell Counters, Cell Imaging Systems, Flow Cytometers, Cell Separator Systems, Automated Cell Processing Systems, and Others), Application, End use, and Region - Market Forecast, 2025–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.

The rising prevalence of chronic diseases and increasing demand for personalized medicine across the globe are expanding the global cell processing instruments market. Chronic conditions such as cancer, diabetes, and autoimmune disorders necessitate cell-based therapies like CAR-T cell therapy or stem cell therapy. Cell processing instruments play a crucial role in preparing and altering cells for these therapies. Thus, the increasing prevalence of chronic diseases is fueling the market.

The growing number of clinical trials for cell-based therapies is driving the global cell processing instruments market. Large numbers of cells need to be isolated, expanded, and prepared for treatment in these trials, which results in a need for high-throughput cell processing instruments that efficiently handle large volumes of cells while maintaining high quality and consistency. Therefore, as the number of clinical trials for cell-based therapies increases, the demand for cell processing instruments also increases. For instance, according to a published report, around 2,000 clinical trials for cell and gene therapies were launched globally between 2018 and 2022.

Cell Processing Instruments Market Report Highlights

By type, the cell separator systems segment accounted for the largest market share in 2024 due to its critical role in separating specific cell types from complex mixtures, which is essential for various applications in research, diagnostics, and therapeutic procedures.

The cell imaging systems segment is expected to witness the highest growth rate during the forecast period, owing to the rising need for advanced imaging technologies that provide detailed and dynamic insights into cellular processes.

In terms of applications, the cell isolation/separation segment accounted for the largest market share in 2024, owing to the rising need for isolating specific cell populations for a variety of research and clinical purposes. The increased focus on immunotherapy and regenerative medicine has further boosted demand for cell isolation/separation.

North America accounted for a major share of the market in 2024 due to the presence of advanced healthcare infrastructure, substantial investments in research and development, and a high concentration of prominent biotechnology and pharmaceutical companies.

Asia Pacific is projected to register the fastest growth during 2025–2034, attributable to the increasing rapid economic development and significant improvements in healthcare infrastructure. Additionally, the rising prevalence of chronic diseases and the growing focus on personalized medicine drive the demand for cell-processing instruments in the region.

Danaher; Merck KGaA; Thermo Fisher Scientific Inc.; Agilent Technologies Inc.; BD; Sartorius; Bio-Rad Laboratories; Honeycomb Biotechnologies; Bio-Techne; Revvity Inc.; Miltenyi Biotec; and Cellares are among the global market players.

Polaris Market Research has segmented the cell processing instruments market report on the basis of type, application, end use, and region:

By Type Outlook (Revenue – USD Billion, 2020–2034)

Cell Counters

Cell Imaging Systems

Flow Cytometers

Cell Separator Systems

Automated Cell Processing Systems

Other

By Application Outlook (Revenue – USD Billion, 2020–2034)

Cell Isolation/Separation

Cell Imaging & Counting

Cell Viability & Proliferation

Other

By End use Outlook (Revenue – USD Billion, 2020–2034)

Pharmaceutical & Biotechnology Companies

CROs & CMOs

Academic & Research Institutes

Others

By Regional Outlook (Revenue – USD Billion, 2020–2034)

North America

• US
• Canada
• Europe
• Germany
• UK
• France
• Italy
• Spain
• Russia
• Netherlands
• Rest of Europe
• Asia Pacific
• China
• India
• Japan
• South Korea
• Indonesia
• Malaysia
• Australia
• Rest of Asia Pacific
• Latin America
• Argentina
• Brazil
• Mexico
• Rest of Latin America
• Middle East & Africa
• UAE
• Saudi Arabia
• Israel
• South Africa
• Rest of Middle East & Africa